Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases.

Naseem S, Frank D, Konopka JB, Carpino N.

Infect Immun. 2015 Feb;83(2):637-45. doi: 10.1128/IAI.02789-14. Epub 2014 Nov 24.

2.

Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.

Frank D, Naseem S, Russo GL, Li C, Parashar K, Konopka JB, Carpino N.

MBio. 2018 Jul 17;9(4). pii: e00782-18. doi: 10.1128/mBio.00782-18.

3.

Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.

Parashar K, Kopping E, Frank D, Sampath V, Thanassi DG, Carpino N.

Infect Immun. 2017 Aug 18;85(9). pii: e00406-17. doi: 10.1128/IAI.00406-17. Print 2017 Sep.

4.

Modulating Host Signaling Pathways to Promote Resistance to Infection by Candida albicans.

Carpino N, Naseem S, Frank DM, Konopka JB.

Front Cell Infect Microbiol. 2017 Nov 21;7:481. doi: 10.3389/fcimb.2017.00481. eCollection 2017. Review.

5.

Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.

Martin-Manso G, Navarathna DH, Galli S, Soto-Pantoja DR, Kuznetsova SA, Tsokos M, Roberts DD.

PLoS One. 2012;7(11):e48775. doi: 10.1371/journal.pone.0048775. Epub 2012 Nov 7.

6.

Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans.

Navarathna DH, Lionakis MS, Lizak MJ, Munasinghe J, Nickerson KW, Roberts DD.

PLoS One. 2012;7(10):e48475. doi: 10.1371/journal.pone.0048475. Epub 2012 Oct 29.

7.

Normal host defense during systemic candidiasis in mannose receptor-deficient mice.

Lee SJ, Zheng NY, Clavijo M, Nussenzweig MC.

Infect Immun. 2003 Jan;71(1):437-45.

8.

Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, Menzel F, Arnold B, DiDomenico B, Hare R.

Infect Immun. 2001 Aug;69(8):5046-55.

9.

Cutting edge: Failure of antigen-specific CD4+ T cell recruitment to the kidney during systemic candidiasis.

Drummond RA, Wallace C, Reid DM, Way SS, Kaplan DH, Brown GD.

J Immunol. 2014 Dec 1;193(11):5381-5. doi: 10.4049/jimmunol.1401675. Epub 2014 Oct 24.

10.

Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Mullick A, Elias M, Picard S, Bourget L, Jovcevski O, Gauthier S, Tuite A, Harakidas P, Bihun C, Massie B, Gros P.

Infect Immun. 2004 Oct;72(10):5868-76.

11.

Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.

Spellberg B, Johnston D, Phan QT, Edwards JE Jr, French SW, Ibrahim AS, Filler SG.

Infect Immun. 2003 Oct;71(10):5756-64.

12.

A limited role of iNKT cells in controlling systemic Candida albicans infections.

Tarumoto N, Kinjo Y, Ueno K, Okawara A, Watarai H, Taniguchi M, Maesaki S, Miyazaki Y.

Jpn J Infect Dis. 2012;65(6):522-6.

13.

Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.

Blumstein GW, Parsa A, Park AK, McDowell BL, Arroyo-Mendoza M, Girguis M, Adler-Moore JP, Olson J, Buckley NE.

PLoS One. 2014 Jul 24;9(7):e103288. doi: 10.1371/journal.pone.0103288. eCollection 2014.

14.

The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis.

Ifrim DC, Quintin J, Courjol F, Verschueren I, van Krieken JH, Koentgen F, Fradin C, Gow NA, Joosten LA, van der Meer JW, van de Veerdonk F, Netea MG.

J Interferon Cytokine Res. 2016 Apr;36(4):267-76. doi: 10.1089/jir.2015.0040. Epub 2016 Jan 27.

15.

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge.

Whibley N, Maccallum DM, Vickers MA, Zafreen S, Waldmann H, Hori S, Gaffen SL, Gow NA, Barker RN, Hall AM.

Eur J Immunol. 2014 Apr;44(4):1069-83. doi: 10.1002/eji.201343604. Epub 2014 Feb 13.

16.

Fas-FasL interactions modulate host defense against systemic Candida albicans infection.

Netea MG, van Der Meer JW, Meis JF, Kullberg BJ.

J Infect Dis. 1999 Nov;180(5):1648-55.

PMID:
10515828
17.

Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.

Yang YL, Wang CW, Chen CT, Wang MH, Hsiao CF, Lo HJ.

Mycol Res. 2009 Mar;113(Pt 3):388-90. doi: 10.1016/j.mycres.2008.11.016. Epub 2008 Dec 16.

PMID:
19111931
18.

Intestinal colonization by Candida albicans alters inflammatory responses in Bruton's tyrosine kinase-deficient mice.

Strijbis K, Yilmaz OH, Dougan SK, Esteban A, Gröne A, Kumamoto CA, Ploegh HL.

PLoS One. 2014 Nov 7;9(11):e112472. doi: 10.1371/journal.pone.0112472. eCollection 2014.

19.

Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.

Cutler JE, Corti M, Lambert P, Ferris M, Xin H.

PLoS One. 2011;6(7):e22030. doi: 10.1371/journal.pone.0022030. Epub 2011 Jul 19.

20.

Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.

Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, Kullberg BJ.

J Infect Dis. 2006 May 15;193(10):1419-26. Epub 2006 Apr 4.

PMID:
16619190

Supplemental Content

Support Center